Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Impact of tenofovir alafenamide vs. entecavir on hepatocellular carcinoma risk in patients with chronic hepatitis B
Hye Won Lee, Young Youn Cho, Hyein Lee, et al.
Hepatology International (2021) Vol. 15, Iss. 5, pp. 1083-1092
Open Access | Times Cited: 22

Showing 22 citing articles:

2022 KLCA-NCC Korea practice guidelines for the management of hepatocellular carcinoma

Clinical and Molecular Hepatology (2022) Vol. 28, Iss. 4, pp. 583-705
Open Access | Times Cited: 195
2022 KLCA-NCC Korea Practice Guidelines for the Management of Hepatocellular Carcinoma

Korean Journal of Radiology (2022) Vol. 23, Iss. 12, pp. 1126-1126
Open Access | Times Cited: 90
2022 KLCA-NCC Korea practice guidelines for the management of hepatocellular carcinoma

Journal of Liver Cancer (2022) Vol. 23, Iss. 1, pp. 1-120
Open Access | Times Cited: 83
Risk of Hepatocellular Carcinoma With Tenofovir vs Entecavir Treatment for Chronic Hepatitis B Virus
Darren Jun Hao Tan, Cheng Han Ng, Phoebe Wen Lin Tay, et al.
JAMA Network Open (2022) Vol. 5, Iss. 6, pp. e2219407-e2219407
Open Access | Times Cited: 34
Hepatitis B Virus Treatment and Hepatocellular Carcinoma: Controversies and Approaches to Consensus
Soo Ki Kim, Takako Fujii, Soo Ryang Kim, et al.
Liver Cancer (2022) Vol. 11, Iss. 6, pp. 497-510
Open Access | Times Cited: 29
Lower risk of hepatocellular carcinoma with tenofovir than entecavir treatment in subsets of chronic hepatitis B patients: an updated meta‐analysis
Bao‐Hong Yuan, Ru‐Hong Li, Rong‐Rui Huo, et al.
Journal of Gastroenterology and Hepatology (2022) Vol. 37, Iss. 5, pp. 782-794
Open Access | Times Cited: 25
Tenofovir alafenamide versus entecavir in treating patients with chronic hepatitis B: A meta-analysis
Jian-Xing Luo, Guo Chen, Xiao Hu, et al.
Gastroenterología y Hepatología (English Edition) (2025) Vol. 48, Iss. 4, pp. 502276-502276
Closed Access
Efficacy of entecavir, tenofovir disoproxil fumarate, and tenofovir alafenamide in treatment-naive hepatitis B patients
Hye Yeon Chon, Sang Hoon Ahn, Yoon Jun Kim, et al.
Hepatology International (2021) Vol. 15, Iss. 6, pp. 1328-1336
Closed Access | Times Cited: 22
Noninferiority Outcomes of Besifovir Compared to Tenofovir Alafenamide in Treatment-Naïve Patients with Chronic Hepatitis B
Tae Hyung Kim, Ji Hoon Kim, Hyung Joon Yim, et al.
Gut and Liver (2024) Vol. 18, Iss. 2, pp. 305-315
Open Access | Times Cited: 2
Lower Incidence of Hepatocellular Carcinoma with Tenofovir Alafenamide in Chronic Hepatitis B: Evidence from a Large-Scale Cohort
Hyejin Yoo, Jin Young Kim, Jeong‐Ju Yoo, et al.
JHEP Reports (2024) Vol. 7, Iss. 2, pp. 101268-101268
Open Access | Times Cited: 2
Prediction model of hepatitis B virus-related hepatocellular carcinoma in patients receiving antiviral therapy
Beom Kyung Kim, Sang Hoon Ahn
Journal of the Formosan Medical Association (2023) Vol. 122, Iss. 12, pp. 1238-1246
Open Access | Times Cited: 6
Hepatitis B Before and After Hepatocellular Carcinoma
Murat Harputluoğlu, Brian I. Carr
Journal of Gastrointestinal Cancer (2021) Vol. 52, Iss. 4, pp. 1206-1210
Closed Access | Times Cited: 14
The association between hepatocarcinogenesis and intracellular alterations due to hepatitis B virus infection
Masataka Tsuge
Liver International (2021) Vol. 41, Iss. 12, pp. 2836-2848
Open Access | Times Cited: 8
Novel Liver Stiffness-Based Nomogram for Predicting Hepatocellular Carcinoma Risk in Patients with Chronic Hepatitis B Virus Infection Initiating Antiviral Therapy
Jae Seung Lee, Hyun Woong Lee, Tae Seop Lim, et al.
Cancers (2021) Vol. 13, Iss. 23, pp. 5892-5892
Open Access | Times Cited: 8
TACE versus TACE + entecavir versus TACE + tenofovir in the treatment of HBV associated hepatocellular carcinoma
Haohao Lu, Chuansheng Zheng, Bin Xiong, et al.
BMC Cancer (2023) Vol. 23, Iss. 1
Open Access | Times Cited: 3
Safety of current antiviral drugs for chronic hepatitis B
Chiara Masetti, Nicola Pugliese, Alessio Aghemo, et al.
Expert Opinion on Drug Safety (2022) Vol. 21, Iss. 7, pp. 939-945
Closed Access | Times Cited: 5
Hepatocellular Carcinoma and Hepatitis: Advanced Diagnosis and Management with a Focus on the Prevention of Hepatitis B-Related Hepatocellular Carcinoma
Soo Ryang Kim, Soo Ki Kim
Diagnostics (2023) Vol. 13, Iss. 20, pp. 3212-3212
Open Access | Times Cited: 2
Liver Carcinogenesis Suppression in Chronic Hepatitis B in the Nucleoside Analogues Era
Hiroki Nishikawa, Soo Ki Kim, Akira Asai
In Vivo (2023) Vol. 38, Iss. 1, pp. 40-47
Open Access | Times Cited: 2
The Age, Gamma-Glutamyl Transpeptidase and Platelet Index: A Novel Noninvasive Model for Predicting Hepatocellular Carcinoma in Patients with Hepatitis B Virus-Related Liver Cirrhosis
Kai Liu, Zeyu Huang, Su-Hua Yang, et al.
Journal of Hepatocellular Carcinoma (2022) Vol. Volume 9, pp. 1057-1063
Open Access | Times Cited: 3
Risk of hepatocellular carcinoma after curative treatment when switching from tenofovir disoproxil fumarate or entecavir to tenofovir alafenamide: A real‐world multicenter cohort study
Hyun‐Jae Shin, Seung Up Kim, Byeong Geun Song, et al.
Hepatology Research (2024) Vol. 54, Iss. 7, pp. 627-637
Closed Access
Validation of PH and Varices Risk Scores for Prediction of High-Risk Esophageal Varix and Bleeding in Patients with B-Viral Cirrhosis
Seung-Hwan Shin, Seung Up Kim, Jun Yong Park, et al.
Diagnostics (2022) Vol. 12, Iss. 2, pp. 441-441
Open Access | Times Cited: 2
Anti-HBV Drugs in Liver Cirrhosis
Qing‐Lei Zeng
(2022), pp. 1-10
Closed Access | Times Cited: 1
Page 1

Scroll to top